BioCryst Pharmaceuticals | BCRX - Pendapatan Penjualan

Harga Saham
8.30
Perubahan Harian
-0.73 -8.08%
Bulanan
-13.45%
Tahunan
-17.66%
Q2 Perkiraan
9.00




Penjualan Perubahan Tanggal
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Chugai Pharma JPY 321.75B 24.55B 2026-03
Daiichi Sankyo JPY 587B 28.89B 2026-03
DBV Technologies USD 2.77M 1.31M 2025-09
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Neurocrine Biosciences USD 811M 5.5M 2026-03
Novavax USD 147.14M 76.69M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03